267 related articles for article (PubMed ID: 32824922)
1.
Stuchi LP; Castanhole-Nunes MMU; Maniezzo-Stuchi N; Biselli-Chicote PM; Henrique T; Padovani Neto JA; de-Santi Neto D; Girol AP; Pavarino EC; Goloni-Bertollo EM
Genes (Basel); 2020 Aug; 11(9):. PubMed ID: 32824922
[TBL] [Abstract][Full Text] [Related]
2. Circular RNA Pvt1 oncogene (CircPVT1) promotes the progression of papillary thyroid carcinoma by activating the Wnt/β-catenin signaling pathway and modulating the ratio of microRNA-195 (miR-195) to vascular endothelial growth factor A (VEGFA) expression.
Zeng L; Yuan S; Zhou P; Gong J; Kong X; Wu M
Bioengineered; 2021 Dec; 12(2):11795-11810. PubMed ID: 34927541
[TBL] [Abstract][Full Text] [Related]
3. NR2F1-AS1 regulated miR-423-5p/SOX12 to promote proliferation and invasion of papillary thyroid carcinoma.
Yang C; Liu Z; Chang X; Xu W; Gong J; Chai F; Cui D
J Cell Biochem; 2020 Feb; 121(2):2009-2018. PubMed ID: 31692033
[TBL] [Abstract][Full Text] [Related]
4. BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis.
Zhang C; Bo C; Guo L; Yu P; Miao S; Gu X
World J Surg Oncol; 2019 Dec; 17(1):221. PubMed ID: 31842912
[TBL] [Abstract][Full Text] [Related]
5. BRAF V600E mutation and microRNAs are helpful in distinguishing papillary thyroid malignant lesions: Tissues and fine needle aspiration cytology cases.
Zarkesh M; Zadeh-Vakili A; Akbarzadeh M; Nozhat Z; Fanaei SA; Hedayati M; Azizi F
Life Sci; 2019 Apr; 223():166-173. PubMed ID: 30890403
[TBL] [Abstract][Full Text] [Related]
6. MiR-181a-5p Regulates NIS Expression in Papillary Thyroid Carcinoma.
Gierlikowski W; Broniarek K; Cheda Ł; Rogulski Z; Kotlarek-Łysakowska M
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34199867
[TBL] [Abstract][Full Text] [Related]
7. Interactions of Vascular Endothelial Growth Factor and p53 with miR-195 in Thyroid Carcinoma: Possible Therapeutic Targets in Aggressive Thyroid Cancers.
Maroof H; Irani S; Arianna A; Vider J; Gopalan V; Lam AK
Curr Cancer Drug Targets; 2019; 19(7):561-570. PubMed ID: 29956628
[TBL] [Abstract][Full Text] [Related]
8. MiR-324-5p/PTPRD/CEBPD axis promotes papillary thyroid carcinoma progression via microenvironment alteration.
Yang Y; Xia S; Zhang L; Wang W; Chen L; Zhan W
Cancer Biol Ther; 2020 Jun; 21(6):522-532. PubMed ID: 32151175
[TBL] [Abstract][Full Text] [Related]
9. Expression profile and clinical significance of microRNAs in papillary thyroid carcinoma.
Peng Y; Li C; Luo DC; Ding JW; Zhang W; Pan G
Molecules; 2014 Aug; 19(8):11586-99. PubMed ID: 25100252
[TBL] [Abstract][Full Text] [Related]
10. Regulation of
Cuzziol CI; Marzochi LL; Possebon VS; Kawasaki-Oyama RS; Mattos MF; Junior VS; Ferreira LAM; Pavarino ÉC; Castanhole-Nunes MMU; Goloni-Bertollo EM
Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806488
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs as regulators of VEGFA and NFE2L2 in cancer.
Cuzziol CI; Castanhole-Nunes MMU; Pavarino ÉC; Goloni-Bertollo EM
Gene; 2020 Oct; 759():144994. PubMed ID: 32721475
[TBL] [Abstract][Full Text] [Related]
12. The stress-activated protein kinase pathway and the expression of stanniocalcin-1 are regulated by miR-146b-5p in papillary thyroid carcinogenesis.
Al-Abdallah A; Jahanbani I; Mehdawi H; Ali RH; Al-Brahim N; Mojiminiyi O
Cancer Biol Ther; 2020 May; 21(5):412-423. PubMed ID: 32037949
[TBL] [Abstract][Full Text] [Related]
13. LncRNA LINC00460 promotes the papillary thyroid cancer progression by regulating the LINC00460/miR-485-5p/Raf1 axis.
Li G; Kong Q
Biol Res; 2019 Dec; 52(1):61. PubMed ID: 31870440
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA circBACH2 plays a role in papillary thyroid carcinoma by sponging miR-139-5p and regulating LMO4 expression.
Cai X; Zhao Z; Dong J; Lv Q; Yun B; Liu J; Shen Y; Kang J; Li J
Cell Death Dis; 2019 Feb; 10(3):184. PubMed ID: 30796202
[TBL] [Abstract][Full Text] [Related]
15. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
Jiang XL; Zhang H; Chen YL; Peng L
Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
[No Abstract] [Full Text] [Related]
16. Validation of MicroRNA-188-5p Inhibition Power on Tumor Cell Proliferation in Papillary Thyroid Carcinoma.
Zhou P; Irving A; Wu H; Luo J; Aguirre J; Costa M; Khamsuree M; Gerads N; Liu W
Cell Transplant; 2020; 29():963689720918300. PubMed ID: 32425116
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical levels of cyclo-oxygenase-2, matrix metalloproteinase-9 and vascular endothelial growth factor in papillary thyroid carcinoma and their clinicopathological correlations.
Meng XY; Zhang Q; Li Q; Lin S; Li J
J Int Med Res; 2014 Jun; 42(3):619-27. PubMed ID: 24670538
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA ASMTL-AS1 inhibits tumor growth and glycolysis by regulating the miR-93-3p/miR-660/FOXO1 axis in papillary thyroid carcinoma.
Feng Z; Chen R; Huang N; Luo C
Life Sci; 2020 Mar; 244():117298. PubMed ID: 31953163
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of five miRNAs in papillary thyroid carcinomas.
Qiao DH; He XM; Deng X; Ji YC; Yang H; Cheng L; Zhou XY
J Clin Lab Anal; 2021 Sep; 35(9):e23907. PubMed ID: 34268792
[TBL] [Abstract][Full Text] [Related]
20. miR-125a-3p suppresses the growth and progression of papillary thyroid carcinoma cell by targeting MMP11.
Song M; Wang N; Li Z; Zhang Y; Zheng Y; Yi P; Chen J
J Cell Biochem; 2020 Feb; 121(2):984-995. PubMed ID: 31489990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
